Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8829076 | Prostate International | 2017 | 9 Pages |
Abstract
Metabolomics of seminal plasma in vitro may assist urologists with diagnosis and monitoring of either low or intermediate grade prostate cancer. Less clinical benefit may be observed for high-risk patients. Further investigation in active surveillance cohorts, and/or in combination with in vivo magnetic resonance spectroscopic imaging may further optimize localized prostate cancer outcomes.
Related Topics
Health Sciences
Medicine and Dentistry
Urology
Authors
Matthew J. Roberts, Renee S. Richards, Clement W.K. Chow, Marion Buck, John Yaxley, Martin F. Lavin, Horst Joachim Schirra, Robert A. Gardiner,